Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Cambrex Corp (CBM)

60.40 -0.50 (-0.82%)

6/23/2017  4:02pm

Open:

60.90

Pre. Close:

60.90

High:

61.70

Low:

60.10

Volume:

378,701

Market Cap:

1.97B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

62.24 - 62.97

62.97 - 63.76

Low:

58.07 - 58.85

58.85 - 59.71

Close:

59.15 - 60.38

60.38 - 61.73

Technical analysis  (as of: 2017-06-23 4:32:59 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 72.07     One year: 84.17

Support:

Support1: 55.40    Support2: 51.50

Resistance:

Resistance1: 61.70    Resistance2: 72.07

Pivot:

57.69

Moving Averages:

MA(5): 59.81     MA(20): 56.70

MA(100): 54.52     MA(250): 51.30

MACD:

MACD(12,26): 1.50     Signal(12,26,9): 1.04

%K %D:

%K(14,3): 89.19     %D(3): 91.17

RSI:

RSI(14): 70.57

52-Week:

High: 62.95  Low: 38.30  Change(%): 22.0

Average Vol(K):

3-Month: 19726  10-Days 274

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CBM has closed below upper band by 11.3%. Bollinger Bands are 5.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 15 Feb 2017 18:45:00 GMT
Cambrex: A Pure Growth Play

Mon, 03 Oct 2016 20:23:45 GMT
Cambrex: Overblown Concerns Present Attractive Entry Opportunity Into Growing ...

Fri, 23 Jun 2017 05:48:45 GMT
Origin Asset Management LLP Maintains Stake in Cambrex Corporation (CBM)

Tue, 19 Jul 2016 15:56:15 GMT
Cambrex Corporation Completes Expansion at Iowa Facility

Mon, 03 Oct 2016 06:56:15 GMT
Cambrex Opens New Pilot Plant at Its Milan, Italy Site

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

32.40

Shares Float (M)

32.15

% Held by Insiders

1.86

% Held by Institutions

90.70

Shares Short (K)

43

Shares Short Prior Month (K)

2440

Stock Financials

EPS

2.630

EPS Est. Current Year

3.020

EPS Est. Next Year

3.240

EPS Est. Next Quarter

0.450

Forward EPS

3.241

Book Value (p.s.)

13.220

PEG Ratio

1.21

Profit Margin

17.37

Operating Margin

27.08

Return on Assets (ttm)

14.5

Return on Equity (ttm)

24.5

Qtrly Rev. Growth

10.8

Gross Profit (p.s.)

6.303

Sales Per Share

EBITDA (p.s.)

4.995

Qtrly Earnings Growth

36.20

Operating Cash Flow (M)

69.09

Levered Free Cash Flow (M)

21.29

FoxReading.com

Valuation

P/E

22.97

P/E Growth Ratio

-0.01

P/BV

4.57

P/S

126011592.00

P/CF

28.32

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

2007-05-04

Forward Dividend

Last Split Date

Last Split Ratio

2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.